Use of heterocyclic compounds as SCCE inhibitors

Details Use of heterocyclic compounds as SCCE inhibitors Use of heterocyclic compounds as SCCE inhibitors

2011-01-18

2011-01-18

Hartley, Michael G (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Hydrocarbon doai

C514S222800, C424S400000

Reexamination Certificate

active

07872052

ABSTRACT:
The present invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More particularly, the invention relates to the use of compounds with the formula (I) or (II) for treatment of certain diseases, in particular skin diseases such as pruritus, as well as cancer such as ovarian cancer.

REFERENCES:
patent: 4251531 (1981-02-01), Doria et al.
patent: 5073559 (1991-12-01), Coates
patent: 5346886 (1994-09-01), Lezdey et al.
Gilmore et al, Synthesis and Evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as Clr serine protease inhibitors, Bioorganic & Medicinal Chemistry Letters, 1996, 6(6), 679-682.
http://www.merck.com/mmpe/sec10/ch116/ch116b.html (accessed Mar. 20, 2008).
M. Mordarski, et al., “Antitumor properties of 1,3-oxazine derivatives. Derivatives of Dihydro-1,3-Oxazine Condensed with an Aromatic Ring in Position 5,6”Archivum Immunologiae et Therapiae Experimentalis, 1971, 19(4):533-545.
V. Pavlidis, et al., “The Synthesis of a Novel Series of Substituted 2-Phenyl-4H-3,1-benzoxazin-4-ones,”Synth. Commun., 1994, 24(4):533-548.
R. Law et al., “An Overview of the Serpin Superfamily,”Genome Biology, 2006, 7:216-216;11.
D. Curiel et al., “Serum α1—Antitrypsin Deficiency Associated with the Common S-type (Glu264→Val) Mutation Results from Intracellular Degradation of α1—Antitrypsin Prior to Secretion,” TheJournal of Biological Chemistry, 1989, vol. 264, No. 18, Issue of Jun. 25, 10477-10486.
Peter G. W. Gettins, “Serpin Structure, Mechanism, and Function,” Chem. Rev., 2002, 102, 4751-4803.

Affiliated with

Also associated with

Rating

Use of heterocyclic compounds as SCCE inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of heterocyclic compounds as SCCE inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of heterocyclic compounds as SCCE inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2693144